MRG003 Clinical Trials

3 actively recruiting trials

No change since August 2026

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 1

Top Sponsors

Lepu Biopharma Co., Ltd.1
Jiyan Liu1
Groupe Oncologie Radiotherapie Tete et Cou1

Indications

Cancer3
Locally Advanced Head and Neck Squamous Cell Carcinoma1
Squamous Cell Carcinoma of the Head and Neck1
Penile Cancer1

Other3 trials

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

Phase 3

Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck

Phase 2

MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.